Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Conditions
Neuroendocrine Tumors Unresectable · Neuroendocrine Tumor Metastatic · Gastroenteropancreatic Neuroendocrine Tumor · Bronchial Neuroendocrine Tumor · Paraganglioma · Pheochromocytoma · Meningioma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic, Jacksonville, Florida, United States
Contact: Principal Investigator (Jason Starr, MD)Biogenix Molecular, Miami, Florida, United States
Contact: Principal Investigator (Frankis Almaguel, MD)The University of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Chih-Yi Liao, MD)University of Iowa, Iowa City, Iowa, United States
Contact: Principal Investigator (Yusuf Menda, MD)University of Kentucky, Lexington, Kentucky, United States
Contact: Principal Investigator (Lowell Anthony, MD, FACP)Johns Hopkins, Baltimore, Maryland, United States
Contact: Principal Investigator (Seyed Ali Mosallaie, MD)Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Contact: Principal Investigator (Anthony Shields, M.D., Ph.D)BAMF Health, Grand Rapids, Michigan, United States
Contact: Study coordinator (BAMF Health Clinical Research Team) · researchclinicalteam@bamfhealth.com · 616-330-2735Contact: Principal Investigator (Brandon Mancini, MD)Michigan Health Professionals, Troy, Michigan, United States
Contact: Principal Investigator (Savitha Balaraman, MD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Thorvardur R Halfdanarson, MD)Washington University, St Louis, Missouri, United States
Contact: Principal Investigator (Richard Wahl, MD)Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Principal Investigator (Samuel Mehr, MD)University of North Carolina, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Jared Weiss, MD)UH Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Principal Investigator (Amr Mohamed, MD)Ohio State University, Columbus, Ohio, United States
Contact: Principal Investigator (Vineeth Sukrithan, M.D.)Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Robert Ramirez, DO)Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Principal Investigator (Gregory Sibley, MD)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Principal Investigator (Amir Iranvani, MD)Froedtert Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Alexandria Phan, MD, FACP)